Clinical Trials Directory

Trials / Unknown

UnknownNCT05802381

the Safety and Effectiveness of Protein Supplements on Cancer Patients With Nutritional Risk and Malnutrition

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Peking Union Medical College Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Nutritional risk and malnutrition is common in cancer patients, which is one of the significant factors affecting the overall survival, toxicity during anticancer treatment, and quality of life among patients with cancer. Previous studies have shown that the increased protein intake can stimulate muscle synthesis, and improve muscle mass, strength, function, overall survival, and quality of life. The current study is going to investigate the effectiveness and safety of protein supplements on patients with cancer, in order to provide a reference for further nutrition treatment.

Detailed description

An anticipated total of 100 participants will randomly assigned to receive either a 20-gram protein supplement per day or nutrition counseling to increase the protein intake. there will be a total of 3 study visits, and dietary assessment and blood sample collection will occur at every study visit. Intention-to-treat analysis (ITT) and per-protocol analysis (PP) will be used in statistical analysis.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTprotein supplement20 gram protein supplement per day
BEHAVIORALnutrition counselingnutrition counseling for guidance of food intake

Timeline

Start date
2023-04-01
Primary completion
2024-04-01
Completion
2024-12-01
First posted
2023-04-06
Last updated
2023-04-06

Source: ClinicalTrials.gov record NCT05802381. Inclusion in this directory is not an endorsement.